|

Arthritis Clinical Trials in Arlington, TX

35 recruiting studies within 50 miles

Phase
Trial Phase Dist.
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)Phase 2<1 mi
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.Phase 2<1 mi
FX Shoulder Prospective Clinical Study—8 mi
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial DiseasePhase 410 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)Phase 410 mi
Study of GS-0272 in Participants With Rheumatoid ArthritisPhase 110 mi
RA-PRO PRAGMATIC TRIALPhase 310 mi
Ultrasound Neuroimmune Modulation in Adults With Rheumatoid ArthritisPhase 210 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic DrugPhase 310 mi
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsPhase 110 mi
Guselkumab vs Golimumab in PsA TNF Inadequate Responder PatientsPhase 310 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)Phase 310 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponsePhase 310 mi
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic ArthritisPhase 311 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightPhase 312 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesPhase 312 mi
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic PainPhase 212 mi
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable CancerPhase 112 mi
A Study of Dotinurad Versus Allopurinol in Participants With GoutPhase 318 mi
ConsideRAte Study - Splenic Stimulation for RAN/A18 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry—18 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the KneePhase 318 mi
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.Phase 318 mi
A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the KneePhase 218 mi
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)Phase 118 mi
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisPhase 220 mi
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid ArthritisPhase 230 mi
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic ArthritisPhase 330 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesPhase 330 mi
Nipocalimab in Moderate to Severe Sjogren's DiseasePhase 331 mi
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's SyndromePhase 331 mi
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's DiseasePhase 131 mi
MDR - PMCF Study for Taperloc Complete Stems—31 mi
A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic ArthritisPhase 336 mi
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE ParticipantsPhase 136 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.